Production of a particulate hepatitis C vaccine candidate by an engineered Lactococcus lactis strain.
about
New skin test for detection of bovine tuberculosis on the basis of antigen-displaying polyester inclusions produced by recombinant Escherichia coli.Vaccines displaying mycobacterial proteins on biopolyester beads stimulate cellular immunity and induce protection against tuberculosis.Bioengineering a bacterial pathogen to assemble its own particulate vaccine capable of inducing cellular immunity.Engineering mycobacteria for the production of self-assembling biopolyesters displaying mycobacterial antigens for use as tuberculosis vaccine.Bioengineering of bacteria to assemble custom-made polyester affinity resinsCXCR4(+)-targeted protein nanoparticles produced in the food-grade bacterium Lactococcus lactis.Protective T Cell and Antibody Immune Responses against Hepatitis C Virus Achieved Using a Biopolyester-Bead-Based Vaccine Delivery System.Self-assembled particulate PsaA as vaccine against Streptococcus pneumoniae infection.Engineering bacteria to manufacture functionalized polyester beads.Expanding the recombinant protein quality in Lactococcus lactis.Biomedical Applications of Polyhydroxyalkanoates.Bioengineered polyester beads co-displaying protein and carbohydrate-based antigens induce protective immunity against bacterial infection.Immobilization of alkaline polygalacturonate lyase from Bacillus subtilis on the surface of bacterial polyhydroxyalkanoate nano-granules.Coupled reactions on bioparticles: Stereoselective reduction with cofactor regeneration on PhaC inclusion bodies.
P2860
Q35095115-CB34C381-174A-4B7C-BCF4-B7F140A241F4Q35666220-389345C7-7994-4A34-A29E-D18AB282819BQ37620529-35EE7333-FD2B-47C3-AB04-546BB0331651Q37644063-F92399BB-6622-4FCD-9589-FABC901F445EQ38303377-BC614840-454F-4D70-8934-63726C27B7B7Q39485838-D46D2925-EFF6-4FED-8058-EE9B11837882Q39860495-AC0550D7-D106-44DE-A371-4279BC5026B0Q40240545-CA274E75-01B9-4E41-93FC-82B2872EDD8FQ41828655-F5C8E986-E04E-4071-BC1B-6B5752412D34Q43121684-68967B92-038A-4321-9194-38A372970E12Q47678569-CCE3BBC1-2E4C-40ED-9D9B-34A6DCD7710CQ48138824-7C73A047-1DC1-4B48-AB02-8A95BD844B67Q48332112-A71ED091-29E4-462A-9CC7-511E26F8ABADQ50877630-BBA4495E-584A-46A9-9E9A-B050ED6A8EA3
P2860
Production of a particulate hepatitis C vaccine candidate by an engineered Lactococcus lactis strain.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Production of a particulate he ...... red Lactococcus lactis strain.
@ast
Production of a particulate he ...... red Lactococcus lactis strain.
@en
type
label
Production of a particulate he ...... red Lactococcus lactis strain.
@ast
Production of a particulate he ...... red Lactococcus lactis strain.
@en
prefLabel
Production of a particulate he ...... red Lactococcus lactis strain.
@ast
Production of a particulate he ...... red Lactococcus lactis strain.
@en
P2093
P2860
P356
P1476
Production of a particulate he ...... ered Lactococcus lactis strain
@en
P2093
Jason W Lee
Katrin Grage
Michel Denis
Natalie A Parlane
P2860
P304
P356
10.1128/AEM.06420-11
P407
P577
2011-10-07T00:00:00Z